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Background: Community-acquired pneumonia (CAP) is as a major cause for childhood morbidity and mortality
worldwide. This study was conducted to investigate the adherence and response of the WHO guidelines for
treatment of severe pneumonia.
Method: A cross-sectional study was conducted in the period of June 2009 to July 2010 at Khartoum Hospital,
Sudan. Children admitted and treated for severe pneumonia were enrolled.
Results: Only 39 (18.8%) out of 208 enrolled children received prescriptions that were adherent to the WHO
guidelines of treatment of severe pneumonia. In logistic regression none of the investigated variable (age, gender,
and clinical presentations) was associated with the adherence to the WHO guidelines. There was no significant
difference in the response between adherent and non-adherent prescriptions. There was no association between
the demographic, clinical data, treatment-adherence to the guidelines and the patients’ response.
Conclusion: There is a poor (18.8%) adherence to the WHO guidelines of the treatment of severe pneumonia in
the region regardless to the age, gender and clinical presentation.
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Community-acquired pneumonia (CAP) is as a major
cause for childhood morbidity and mortality worldwide
[1]. World Health Organization has estimated an annual
global incidence of new episodes of pneumonia as156
million, the vast majority of these (151 million) episodes
were reported from the developing countries [2]. The
leading bacterial cause of pneumonia in underdeveloped
countries is pneumococcus (30–50%), H. influenzae type
b (10–30% of cases), S. aureus and K. pneumoniae [3].
Empiric antibacterial selection for treatment of child-
hood CAP must be based on age and the likely causative
organisms [4]. Early and prompt diagnosis of bacterial
pneumonia is lacking in most of the developing coun-
tries, hence empirical treatment is usually practiced.* Correspondence: ishagadam@hotmail.com
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unless otherwise stated.Sudan has one of the highest infant mortality rates (112/
1000 live birth) and respiratory infections are among the
most killing causes [5]. There is no published data ad-
dressing pneumonia/treatment in Sudan. Most hospital
guidelines in developing countries recommend the use
of penicillin and its derivatives for treatment of severe
pneumonia based on the WHO guidelines [6]. Generally,
many clinicians are concerned that guidelines do not re-
flect the complexity of the real situation and may stand
against those who advocate its application in clinical
practice [7].
The objectives of this study were to determine the
adherence to the WHO guidelines for treatment of se-
vere pneumonia and to compare the response to the
treatment between the adherences and an empirical anti-
biotic regimen initially used in the treatment of patients
with severe CAP at the end of 48 hours of starting anti-
biotic in a major pediatric facility in Sudan.d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Clinical manifestation of the children
Variable Frequency (%)
Fever 196 (94.2)
Active alae nasi 175 (93.1)
Intercostal recession 174 (92.6)
Shortness of breathing 192 (92.3)
Cough 181 (88.3)
Runny nose 158 (85.4)
Chest indrawing 154 (81.9)
Grunting 135 (73.4)
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A longitudinal hospital-based study was conducted at
the Children Emergency Hospital (CEH), Khartoum,
Sudan in the period from June 2009 to July 2010. CEH
is the main urban children referral hospital in Sudan
with the capacity of 240 beds and a catchment popula-
tion of more than five million people representing the
population of the tripartite metropolis, Khartoum [8].
After signing an informed consent (by the parents/
guardian) all consecutively admitted children aged 2 to
59 month with definite labeling diagnosis of “severe
pneumonia”, based on the WHO criteria for diagnosis of
pneumonia were included [6]. The critically ill children,
children with known TB, HIV, bronchial asthma, other
chronic conditions that might be complicated by pneu-
monia and those who refuse to be enrolled in the study
were excluded. A radiologist reviewed the chest radio-
graphs (CXR) taken for every child satisfying the WHO
criteria for severe pneumonia at the time of admission.
Only those with evidence of lobar or segmental consoli-
dation or with an infiltrate in at least one lung on chest
radiographs were included.
The investigators recorded demographic, clinical and
treatment data as prescribed and written by the treating
physicians from patients files at the time of admission
and at day 2 to determine response or failure to the anti-
bacterial treatment. Evaluation data include symptoms
(cough, inability to drink, vomiting, lethargy), clinical
signs (tachypnea, temperature of ≥37.5°C, signs of re-
spiratory distress, grunting and full chest examination).
A patient was labeled “responding” if the respiratory rate
returned to age specific normal range, less fever and
eating better after 48 hours following prescription [6].
The patient was labeled “not responding” if respiratory
rate did not return to age-specific normal at the end of
48 hours of antibiotic treatment, still febrile and/not
eating better.
Ethical consideration
The Development and Ethics Committee of Khartoum
Children Emergency Hospital approved this study prior
to collecting data.
Statistical analyses
Data were entered and analyzed into SPSS statistical
software version 16.0 (SPSS Inc., Chicago, IL, U.S.A.
2007). The descriptive analyses used included the mean,
standard deviation, and frequency distribution. Chi
square test was used to compare the difference between
categorical data. Univariate and multivariate analyses
were performed where adherence (penicillin prescrip-
tion) was the dependent variable and the other variables
(age, gender, symptoms) were the independent variable.
Another model was performed for the outcome oftreatment. Odds ration and 95% confidence interval (CI)
were calculated and P < 0.05 was considered significant.
Results
Two hundred and eight children fulfilled the inclusion
criteria in this study. Table 1 shows the demographic
and clinical characteristics of the studied group. The
mean (SD) of the age was 28.12 (13.9) months and 99
(47.6%) were males. Only 39 (18.8%) of these children
received the prescription that was adherent to the WHO
guidelines (penicillin) of severe pneumonia.
The antimicrobial prescriptions, which were not in
accordance with the WHO guidelines, were: amoxicillin/
clavulanic acid (46, 22.1%), ceftriaxone (42, 20.2%), cefu-
roxime (41, 19.7%), a combination of penicillin/gentamicin
(29; 13.9%) and others 11 (11, 5.3%).
None of the investigated factors (age, gender, symp-
toms and signs) were found as predictors for adherence
of the WHO guidelines for treatment of severe pneumo-
nia, Table 2.
There was no significant difference in the response
between adherence and non-adherence prescriptions
[32/39 (82.1%) vs. 151/169 (81.2%), P = 0.206]. None of
the investigated predictors was found to be associated
with treatment outcome as shown, Table 3.
Discussion
The WHO has stressed on the accountability and acces-
sibility of the health information and data at the country
level to measure and monitor results. The data col-
lection on children health is essential to determine for
focusing of investments and progress monitoring [9].
The main findings in this study were that there was poor
adherence to the WHO guidelines of treatment of severe
pneumonia in under-five year old children. The almost
82% of non-adherence to the WHO guidelines of severe
pneumonia in children indicated that patients did not
receive the appropriate medication to their clinical needs
and the antibiotics were not at the lowest cost to them
and their community. This almost defines an irratio-
nal use of antibiotics [10]. The Sudan Association of
Table 2 Factors associated with adherence to WHO
guidelines of treatment of severe pneumonia in the
study using univariate analyses
Variables OR (95% CI) P value
Age 0.9 (0.9 − 1.1) 0.902
Sex 1.3 (0.6 − 2.81) 0.380
Fever 0.8 (0.1 − 4.0) 0.849
Cough 0.8 (0.2 − 26.9) 0.530
Runny nose 0.9 (0.4 − 2.2) 0.913
Breathlessness 0.5 (0.1 − 2.7) 0.742
Grunting 0.8 (0.3 − 1.9) 0.838
Active alae nasi 1.1 (0.3 − 3.7) 0.761
Intercostal recession 1.8 (0.5 − 6.1) 0.304
Chest indrawing 1.1 (0.4 − 2.8) 0.645
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for treatment of emergency conditions in children in-
cluding pneumonia in 2011. Though this protocol was
not validated and did not take effect in clinical practice,
yet the adherence in this study was not in compliance
with its treatment guidelines [11]. The non-adherence
rate was higher than that reported from Burkina Faso.
Their estimate was around 61% though it was an
estimate of compliance for pneumonia among other dis-
eases yet it is here as well [12]. Moreover the prescribing
personnel, in their report, were nurses and health workers
and not physicians as in our study. In a Tanzanian study,
half of the children with severe pneumonia were pre-
scribed antibiotics, which are not recommended by the
WHO [13]. Even in developed countries, the compliance
to privileged countries guidelines is not usually perfect
despite good training, a fact, which was illustrated in one
study where even, restricted initial broad-spectrumTable 3 Factors associated with outcome of treatment of
severe pneumonia in children in the study using
univariate and multivariate analyses
Variables Univariate Multivariate
OR (95% CI) P OR (95% CI) P
Adherence 0.5 (0.2 − 1.4) 0.271 2.3 (0.8 − 6.6) 0.099
Age 0.8 (0.18 − 4.09) 0.849 0.9 (0.9 − 1.1) 0.255
Sex 0.8 (0.2 − 2.6) 0.530 0.8 (0.3 − 2.1) 0.701
Clinical 0.9 (0.4 − 2.2) 0.913 1.0 (0.3 − 3.4) 0.925
Cough 0.9 (0.2 − 3.5) 0.961 1.2 (0.2 − 5.8) 0.753
Runny nose 2.9 (1.2 − 7.1) 0.017 0.3 (0.1 − 1.4) 0.065
Breathlessness 2.1 (0.2 − 16.9) 0.470 0.4 (0.1 − 4.0) 0.479
Grunting 0.6 (0.2 − 1.3) 0.429 1.6 (0.5 − 4.9) 0.376
Active alae nasi 1.1 (0.2 − 5.4) 0.834 0.7 (0.9 − 5.7) 0.770
Intercostal recession 1.8 (0.2 − 14.6) 0.567 0.3 (0.1 − 2.9) 0.362
Chest indrawing 2.0 (0.2 − 15.9) 0.512 2.2 (0.5 − 4.9) 0.116antimicrobial therapy to cultured pathogens was a rare
practice [14]. The statement of the guidelines might not
be clear, especially for junior physicians as well as it was
not endorsed by the senior physicians who used to train
them. Tis might, possibly be, because they were not con-
vinced of the recommended antibiotic in the guidelines
however, studies on knowledge attitude and behavior to-
wards formal guidelines may well explain this point.
The fact that there was no difference in treatment out-
come when following the WHO guidelines or using
alternative antibiotics, in this study, may serve adherence
to the guidelines until prove otherwise. A similar finding
was reported in a Kenyan survey where poor guideline
adherence was attributed to preferences for broader
spectrum, non-beta-lactam antibiotics [15]. Moreover,
another Kenyan study reported a lower rate (48.3%)
among children with pneumonia in which prescription
had improved to 90% adherence after intervention
(training and booklet distribution) [16]. This praises
training as an important tool in improving adherence
and thus better outcome of pneumonia in children.
Antibiotics prescribed in this study except for penicil-
lin do not follow any of the international guidelines.
Commonly used antibiotics for severe pneumonia in an
African setting were penicillin, sulphonamides, and ami-
noglycosides [17]. Amoxicillin and sulphonamides were
the commonly encountered prescriptions in manage-
ment of pneumonia in other areas too e.g. Tanzania and
rural Peru [12,18]. The results of a Sudanese survey in
prescribing patterns proved that at least some parts of
population are unable to afford treatment for some
important and common diseases including childhood
pneumonia and an average 66% rate of antibiotics pre-
scription [19]. The variable antibiotic prescription may
depend not only on guidelines unacceptability among
physicians but also on health provider characteristics,
experience and attitude [15]. Moreover, the health facil-
ities settings and equipment may be an important factor.
This study showed no correlation between clinical pre-
sentation and treatment outcome of severe pneumonia
in children. However, duration of fever, rather than mere
fever and tachypnea were documented as strong predic-
tors for diagnosis of pneumonia rather than outcome in
one study [20]. Another study reported tachypnea and
chest indrawing as best predictors of pneumonia severity
[21]. An extended evaluation in further studies is amen-
able to assess the morbidity and mortality of guideline-
based treatment pneumonia in this age group.
This study did not address the health system, physician
and family factors that may influence the implementa-
tion of the guidelines and the long-term outcome of
children such as mortality. It was not the aim of this
work, albeit useful, to study the cure rate, the full
recovery and mortality of the children with severe
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admission was not recorded as well as supportive the-
rapy. However this study, to the best of our knowledge,
is the first of its type to determine physicians’ adherence
to health policies in Sudan. The relatively reasonable
sample in this study enabled us to draw conclusions on
the adherence to the widely practiced WHO guidelines
and the pattern of antibiotic prescription in a developing
country.
Conclusion
The non-adherence to WHO guidelines of severe pneu-
monia is the highest in the region (82%) regardless to the
age and gender. There was no difference in the response
between adherence and non-adherence. Studies are
needed to determine physician and family factors influen-
cing the implementation of the guidelines and their effects
on the long term.
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